Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C121776
http://purl.obolibrary.org/obo/NCIT_C121776
|
|---|---|
| Preferred Name | Cancer Peptide Vaccine S-588410 |
| Definitions |
A cancer peptide vaccine containing five human leukocyte antigen (HLA)-A*2402-restricted epitope peptides derived from as of yet not disclosed oncoantigens, with potential immunostimulating and antineoplastic activities. Upon administration of the cancer peptide vaccine S-588410, the peptides may stimulate a cytotoxic T-lymphocyte (CTL) response against cancer cells expressing the antigens. This decreases proliferation of susceptible tumor cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cancer peptide vaccine containing five human leukocyte antigen (HLA)-A*2402-restricted epitope peptides derived from as of yet not disclosed oncoantigens, with potential immunostimulating and antineoplastic activities. Upon administration of the cancer peptide vaccine S-588410, the peptides may stimulate a cytotoxic T-lymphocyte (CTL) response against cancer cells expressing the antigens. This decreases proliferation of susceptible tumor cells. |
|---|---|
| prefLabel | Cancer Peptide Vaccine S-588410
|
| label | Cancer Peptide Vaccine S-588410
|
| PDQ_Closed_Trial_Search_ID | 770997
|
| code | C121776
|
| prefixIRI | NCIT:C121776
|
| in_subset | |
| Preferred_Name | Cancer Peptide Vaccine S-588410
|
| Maps_To | Cancer Peptide Vaccine S-588410
|
| NCI_Drug_Dictionary_ID | 770997
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 770997
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C4053593
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |